Current frontline endocrine treatment options for women with hormone receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced-stage breast cancer

Hematology/ Oncology and Stem Cell Therapy, 2019, 12, 1-9

Citation of paper, Current frontline endocrine treatment options for women with hormone receptor-positive, Human Epidermal Growth Factor Receptor 2 (HER2)-negative advanced-stage breast cancer

Authors Citing This Paper

Author	Citing Papers	Author's Papers	Author's Citations	Author's IF
Sarah L Sammons	1	21	143	1.9
Fumie Fujisawa	1	2	2	0.8

Journals Citing This Paper

Journal	Citing Papers	Journal's IF	Journal's Star
Targeted Oncology	1	5	★★★
Current Problems in Cancer	1	2.3	★★★
Future Oncology	1	3.6	★★★

Quick Tips

This is an overview of where and by who this paper has been cited.

Help Us

Non-profit projects normally ask for donations. We don't. We will survive one way or another. If you wish to help us, please spread the word to let more people use this service.

It is delightful to see our efforts are useful to a broad range of researchers.